The firm also shared validation data at ASCO 2021 on its nasal swab classifier to help guide treatment decisions for patients with indeterminate lung nodules.
Veracyte to Acquire HalioDx for €260M
Veracyte said the acquisition will help accelerate its in vitro diagnostic test development and manufacturing operations in Europe.
HalioDx Signs Brazilian Distribution Deal for Colon Cancer Risk Test
The test, called Immunoscore, is designed to predict the risk of relapse in early-stage colon cancer by measuring host immune responses at tumor sites.
HalioDx, FFCD Collaborate for Phase II Metastatic Colorectal Cancer Trial
HalioDx's Immunoscore test, which measures host immune response at the tumor site, will be used to select patients for the trial.
HalioDx, OSE Immunotherapeutics Collaborate on Immune Biomarkers for NSCLC Treatment
HalioDx will perform immune biomarker exploratory work for the collaboration, which will focus on defining the profile of responder patients to Tedopi.